Your browser doesn't support javascript.
loading
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo.
Dowdle, William E; Nyfeler, Beat; Nagel, Jane; Elling, Robert A; Liu, Shanming; Triantafellow, Ellen; Menon, Suchithra; Wang, Zuncai; Honda, Ayako; Pardee, Gwynn; Cantwell, John; Luu, Catherine; Cornella-Taracido, Ivan; Harrington, Edmund; Fekkes, Peter; Lei, Hong; Fang, Qing; Digan, Mary Ellen; Burdick, Debra; Powers, Andrew F; Helliwell, Stephen B; D'Aquin, Simon; Bastien, Julie; Wang, Henry; Wiederschain, Dmitri; Kuerth, Jenny; Bergman, Philip; Schwalb, David; Thomas, Jason; Ugwonali, Savuth; Harbinski, Fred; Tallarico, John; Wilson, Christopher J; Myer, Vic E; Porter, Jeffery A; Bussiere, Dirksen E; Finan, Peter M; Labow, Mark A; Mao, Xiaohong; Hamann, Lawrence G; Manning, Brendan D; Valdez, Reginald A; Nicholson, Thomas; Schirle, Markus; Knapp, Mark S; Keaney, Erin P; Murphy, Leon O.
Afiliação
  • Dowdle WE; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Nyfeler B; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
  • Nagel J; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Elling RA; Novartis Institutes for BioMedical Research, 4560 Horton Street Emeryville, California 94608, USA.
  • Liu S; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Triantafellow E; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Menon S; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Wang Z; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Honda A; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Pardee G; Novartis Institutes for BioMedical Research, 4560 Horton Street Emeryville, California 94608, USA.
  • Cantwell J; Novartis Institutes for BioMedical Research, 4560 Horton Street Emeryville, California 94608, USA.
  • Luu C; Novartis Institutes for BioMedical Research, 4560 Horton Street Emeryville, California 94608, USA.
  • Cornella-Taracido I; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Harrington E; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Fekkes P; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Lei H; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Fang Q; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Digan ME; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Burdick D; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Powers AF; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Helliwell SB; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
  • D'Aquin S; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
  • Bastien J; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.
  • Wang H; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Wiederschain D; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Kuerth J; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Bergman P; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Schwalb D; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Thomas J; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Ugwonali S; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Harbinski F; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Tallarico J; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Wilson CJ; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Myer VE; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Porter JA; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Bussiere DE; Novartis Institutes for BioMedical Research, 4560 Horton Street Emeryville, California 94608, USA.
  • Finan PM; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Labow MA; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Mao X; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Hamann LG; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Manning BD; Department of Genetics and Complex Diseases, Harvard School of Public Health, 665 Huntington Avenue, Boston, Massachusetts 02115, USA.
  • Valdez RA; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Nicholson T; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Schirle M; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Knapp MS; Novartis Institutes for BioMedical Research, 4560 Horton Street Emeryville, California 94608, USA.
  • Keaney EP; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
  • Murphy LO; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
Nat Cell Biol ; 16(11): 1069-79, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25327288
ABSTRACT
Cells rely on autophagy to clear misfolded proteins and damaged organelles to maintain cellular homeostasis. In this study we use the new autophagy inhibitor PIK-III to screen for autophagy substrates. PIK-III is a selective inhibitor of VPS34 that binds a unique hydrophobic pocket not present in related kinases such as PI(3)Kα. PIK-III acutely inhibits autophagy and de novo lipidation of LC3, and leads to the stabilization of autophagy substrates. By performing ubiquitin-affinity proteomics on PIK-III-treated cells we identified substrates including NCOA4, which accumulates in ATG7-deficient cells and co-localizes with autolysosomes. NCOA4 directly binds ferritin heavy chain-1 (FTH1) to target the iron-binding ferritin complex with a relative molecular mass of 450,000 to autolysosomes following starvation or iron depletion. Interestingly, Ncoa4(-/-) mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells. Taken together, the results of this study provide a new mechanism for selective autophagy of ferritin and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autofagia / Coativadores de Receptor Nuclear / Ferritinas / Classe III de Fosfatidilinositol 3-Quinases / Homeostase / Ferro Limite: Animals / Humans Idioma: En Revista: Nat Cell Biol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autofagia / Coativadores de Receptor Nuclear / Ferritinas / Classe III de Fosfatidilinositol 3-Quinases / Homeostase / Ferro Limite: Animals / Humans Idioma: En Revista: Nat Cell Biol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos